← Back to all trials
Completed
NCT02996396
Nellix Registry Study: EVAS-Global
Conditions: Abdominal Aortic Aneurysm
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 48
Sponsor: Endologix
Location: Klinikum Augsburg Klinik für Gefäßchirurgie Augsburg
Summary
Multicenter, single arm, open label, registry study with consecutive, eligible patient enrollment at each site. All subjects undergoing the Endovascular Aneurysm Sealing System (EVAS) with the Nellix®-System. Subjects will be followed procedurally to discharge, and as per institutional standard of care thereafter through to 5 years (total follow-up commitment)
Eligibility Criteria
Inclusion Criteria:
1. Male or female at least 18 years old
2. Subject has signed informed consent for data release
3. Subjects with with AAA and eligible for endovascular repair
Exclusion Criteria:
1. Currently participating in another study where primary endpoint has not been reached yet
2. Known allergy to any of the device components
3. Pregnant (females of childbearing potential only)
Source: ClinicalTrials.gov (NCT02996396). StuddyBuddy aggregates publicly available trial information.
